Percutaneous coronary intervention for small-vessel coronary disease: highlight on the everolimus-eluting stent

References

• Moreno R, Fernandez C, Alfonso F et al. Coronary stenting versus balloon angioplasty in small vessels: a meta-analysis from 11 randomized studies. J. Am. Coll. Cardiol.43, 1964–1972 (2004).
   PubMed Web of Science ®Google Scholar
• Moses JW, Nikolsky E, Mehran R et al.; SIRIUS 2.25 Investigators. Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial. Am. J. Cardiol.98, 1455–1460 (2006).
   PubMed Web of Science ®Google Scholar
• Stone GW, Ellis SG, Cannon L et al.; TAXUS V Investigators. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease. JAMA294, 1215–1223 (2005).
   PubMed Web of Science ®Google Scholar
• Moussa I, Kobayashi Y, Adamian M et al. Characteristics of patients with a large discrepancy in coronary artery diameter between quantitative angiography and intravascular ultrasound. Am. J. Cardiol.88, 294–296 (2001).
   Google Scholar
• Ellis SG, Vandormael MG, Cowley MJ et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation82, 1193–1202 (1990).
   PubMed Web of Science ®Google Scholar
• Hermiller JB Jr. Contemporary treatment of small-vessel disease. J. Invasive Cardiol.16, 417–418 (2004).
   Google Scholar
• Elezi S, Kastrati A, Neumann FJ et al. A vessel size and long-term outcome after coronary stent placement. Circulation98, 1875–1880 (1998).
   PubMed Web of Science ®Google Scholar
• Akiyama T, Moussa I, Reimers B et al. Angiographic and clinical outcome following coronary stenting of small vessels: a comparison with coronary artery stenting of large vessels. J. Am. Coll. Cardiol.32, 1610–1618 (1998).
   PubMed Web of Science ®Google Scholar
• Hausleiter J, Kastrati A, Mehilli J et al. Predictive factors for early cardiac events and angiographic restenosis after coronary stent placement in small coronary arteries. J. Am. Coll. Cardiol.40, 882–889 (2002).
   PubMed Web of Science ®Google Scholar
• Colombo A, Chieffo A. Drug-eluting stent update 2007: part III: technique and unapproved/unsettled indications. Circulation116, 1424–1432 (2007).
   PubMedGoogle Scholar
• Morice MC. Stenting for small coronary vessels. J. Invasive Cardiol.15, 377–379 (2003).
   PubMedGoogle Scholar
• Subbotin VM. Analysis of arterial intimal hyperplasia: review and hypothesis. Theor. Biol. Med. Model.4, 41 (2007).
   PubMed Web of Science ®Google Scholar
• Rajagopal V, Rockson SG. Coronary restenosis: a review of mechanisms and management. Am. J. Med.115, 547–553 (2003).
   PubMed Web of Science ®Google Scholar
• Mauri L, Orav J, O’Malley AJ et al. Relationship of late loss in lumen diameter to coronary restenosis in sirolimus-eluting stents. Circulation111, 321–327 (2005).
   PubMed Web of Science ®Google Scholar
• Ellis SG, Popma JJ, Lasala JM et al. Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trial. J. Am. Coll. Cardiol.45, 1193–1200 (2005).
   PubMed Web of Science ®Google Scholar
• Moreno R, Fernandez C, Sanchez-Recalde A et al. Clinical impact of in-stent late loss after drug-eluting coronary stent implantation. Eur. Heart J.28, 1583–1591 (2007).
   PubMed Web of Science ®Google Scholar
• Agostoni P, Valvimigli M, Abbate A, Cosgrave J, Pilati M, Biondi-Zoccai GGL. Is late loss an accurate predictor of the clinical effectiveness of drug-eluting stents in the coronary arteries? Am. J. Cardiol.97, 603–605 (2006).
   Google Scholar
• Pocock SJ, Lansky AJ, Meran R et al. Angiographic surrogate end points in drug-eluting stens trials. J. Am. Coll. Cardiol.51, 23–32 (2008).
   Google Scholar
• Foley DP, Melkert R, Serruys PW et al. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty. Circulation90, 1239–1251 (1994).
   PubMed Web of Science ®Google Scholar
• Elezi S, Kastrati A, Neumann FJ et al. Vessel size and long-term outcome after coronary stent placement. Circulation98, 1875–1880 (1998).
   PubMed Web of Science ®Google Scholar
• Moses JW, Leon MB, Popma JJ et al. Sirolimus-eluting versus standard stents in patients with stenosis in a native coronary artery. N. Engl. J. Med.349, 1315–1323 (2003).
   PubMed Web of Science ®Google Scholar
• Stone GW, Ellis SG, Cox DA et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N. Engl. J. Med.350, 221–231 (2004).
   PubMed Web of Science ®Google Scholar
• Ardissino D, Cavallini C, Bramuccei E et al. Sirolimus-eluting vs. uncoated stents for prevention of restenosis in small coronary arteries. JAMA292, 2727–2734 (2004).
   PubMed Web of Science ®Google Scholar
• Mehilli J, Dibra A, Kastrati A et al. Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels. Eur. Heart J.27, 260–266 (2006).
   PubMed Web of Science ®Google Scholar
• Tanimoto S, Daemen J, Tsuchida K et al. Two-year clinical outcome after coronary stenting of small vessels using 2.25-mm sirolimus- and paclitaxel-eluting stents: insight into the RESEARCH and T-SEARCH registries. Catheter. Cardiovasc. Interv.69, 94–103 (2007).
   Google Scholar
• Stone GW, Moses JW, Ellis SG et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N. Engl. J. Med.356, 998–1008 (2007).
   PubMed Web of Science ®Google Scholar
• Cosgrave J, Corbett SJ, Melzi G et al. Late restenosis following sirolimus-eluting stent implantation. Am. J. Cardiol.100, 41–44 (2007).
   PubMed Web of Science ®Google Scholar
• Fajadet J, Wijns W, Laarman G-J et al. Randomized, double-blind, multicenter study of the endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial Circulation114, 798–806 (2006).
   PubMed Web of Science ®Google Scholar
• Kandzari DE, Leon MB, Popma JJ et al. Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial. J. Am. Coll. Cardiol.48, 2440–2447 (2006).
   PubMed Web of Science ®Google Scholar
• Leon MB. ENDEAVOR 4: a randomized comparison of a zotarolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: 8-month angiographic and 9- and 12-month clinical results. Presented at: Transcatheter Cardiovascular Therapeutics. Washington, DC, USA, 22 October 2007.
   Google Scholar
• Serruys P, Ruygrok P, Neuzner J et al. A randomized comparison of a durable polymer everolimus-eluting stent with a bare metal coronary stent: the SPIRIT first trial. EuroIntervention1, 58–65 (2005).
   PubMedGoogle Scholar
• Beijk MA, Neumann FJ, Wiemer M et al. Two-year results of a durable polymer everolimus-eluting stent in de novo coronary artery stenosis (the SPIRIT FIRST trial). EuroIntervention3, 206–212 (2007).
   PubMedGoogle Scholar
• Serruys P, Ruygrok P, Neuzner J et al. A randomized comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: the SPIRIT II trial. EuroIntervention2, 286–284 (2006).
   PubMedGoogle Scholar
• Stone GW, Midei M, Newman W et al. Comparison of an evelrolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease. JAMA299, 1903–1913 (2008).
   PubMed Web of Science ®Google Scholar
• Stone GW, Midei M, Newman W et al. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents. Two-year clinical follow-up from the clinical evaluation of the Xience V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions (SPIRIT) III Trial. Circulation119, 680–686 (2009).
   PubMed Web of Science ®Google Scholar
• Stone GW, Rizvi A, Newman W et al.; SPIRIT IV Investigators. Everolimus-eluting versus paclitaxel-eluting stens in coronary artery disease. N. Engl. J. Med.362, 1663–1674 (2010).
   PubMed Web of Science ®Google Scholar
• Marx SO, Marks AR. Bench to bedside: the development of rapamycin and its application to stent restenosis. Circulation104, 852–855 (2001).
   PubMed Web of Science ®Google Scholar
• Carter AJ. TOR of the cell cycle: are there important implications for diabetics in the era of the drug-eluting stent? Catheter. Cardiovasc. Interv.61, 233–236 (2004).
   Google Scholar
• Eisen HJ, Tuzcu EM, Dorent R et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac transplant recipients. N. Engl. J. Med.349, 847–858 (2003).
   PubMed Web of Science ®Google Scholar
• Hagemeister J, Baer FM, Schwinger RH et al. Compliance of a cobalt chromium coronary stent alloy – the COVIS trial. Curr. Control. Trials Cardiovasc. Med.6, 17 (2005).
   Google Scholar
• Carter AJ, Brodeur A, Collingwood R et al. Experimental efficacy of an everolimus eluting cobalt chromium stent. Catheter. Cardiovasc. Interv.68(1), 97–103 (2006).
   PubMed Web of Science ®Google Scholar
• Hermiller JB, Fergus T, Pierson W, Sood P, Sudhir K, Stone GW. Clinical and angiographic comparison of everolimus-eluting and paclitaxel-eluting stents in small coronary arteries: a post hoc analysis of the SPIRIT III randomized trial. Am. Heart J.158, 1005–1010 (2009).
   PubMed Web of Science ®Google Scholar
• Khattab AA, Richardt G, Verin V et al.; SPIRIT II Investigators. Differentiated analysis of an everolimus-eluting stent and a paclitaxel-eluting stent among higher risk subgroups for restenosis: results from the SPIRIT II trial. EuroIntervention3, 566–573 (2008).
   PubMedGoogle Scholar
• Park SW, Lee CW, Hong MK et al. Randomized comparison of coronary stenting with optimal balloon angioplasty for treatment of lesions in small coronary arteries. Eur. Heart J.21, 1785–1789 (2000).
   PubMed Web of Science ®Google Scholar
• Moer R, Nyreng Y, Molstad P et al. Stenting in Small Coronary Arteries (SISCA) trial: a randomized comparison between balloon angioplasty and the heparin-coated beStent. J. Am. Coll. Cardiol.38, 1598–1603 (2001).
   PubMed Web of Science ®Google Scholar
• Koning R, Eltchaninoff H, Commeau P et al.; BESMART (BeStent in Small Arteries) Trial Investigators. Stent placement compared with balloon angioplasty for small coronary arteries: in-hospital and 6-month clinical and angiographic results. Circulation104, 1605–1608 (2001).
   Google Scholar
• Doucet S, Schalij MJ, Vrolix MC et al. Stent in Small Arteries (SISA) trial Investigators. Stent placement to prevent restenosis after angioplasty in small coronary arteries. Circulation104, 2029–2033 (2001).
   PubMed Web of Science ®Google Scholar
• Haude M, Konorza FM, Kalnins U et al.; Heparin-Coated Stents in Small Coronary Arteries (COAST) Trial Investigators. Heparin-coated stent placement for the treatment of stenoses in small coronary arteries of symptomatic patients. Circulation107, 1265–1270 (2003).
   PubMed Web of Science ®Google Scholar
• Garcia E, Gomez-Recio M, Moreno R et al. Stent reduces restenosis in small vessels: results of the RAP study (abstr). J. Am. Coll. Cardiol.37(Suppl. A), 17A (2001).
   Web of Science ®Google Scholar
• Rodriguez AE, Rodriguez MJ, Fernandez C et al. Latin American Randomized Trial of Balloon Angioplasty Vs. Coronary Stenting for Small Vessels (LASMAL): immediate and long-term results. Am. J. Med.118, 743–751 (2005).
   PubMed Web of Science ®Google Scholar
• Hanekamp C, Koolen J, Bonnier H et al. Randomized comparison of balloon angioplasty versus silicon carbon-coated stent implantation for de novo lesions in small coronary arteries. Am. J. Cardiol.93, 1233–1237 (2004).
   PubMed Web of Science ®Google Scholar
• Muramatsu T, Iwasaki K, Inoue N et al. Coronary Heart Disease Stenting in Small Vessels Versus Balloon Angioplasty Study (CHIVAS): a randomized prospective multicenter trial (abstr). J. Am. Coll. Cardiol.39(Suppl. A), 50A (2002).
   Google Scholar
• Tsuchikane E, Takeda Y, Nasu K, Awata N, Kobayashi T. Balloon angioplasty plus cilostazol administration versus primary stenting of small coronary artery disease: final results of COMPASS. Catheter. Cardiovasc. Interv.63, 44–51 (2004).
   Google Scholar